Design / AI-assisted drug discovery
From a candidate to a cure
AI can contribute to finding and prioritizing candidates. The route to a useful medicine still runs through experiments and clinical evidence.
What the evidence shows
Molecular structure prediction and expert-guided hypothesis generation are demonstrated tools relevant to discovery.
What we can reasonably infer
Combining these tools may improve selected discovery workflows, but commercial and clinical advantages need direct measurement.
What remains a possibility
Reliable, inexpensive cures generated entirely in simulation remain beyond what these sources establish.
THE BOUNDARY
Where the claim stops
Binding predictions or promising hypotheses do not show that a drug works in humans. This brief makes no claim about the current approval count for AI-designed drugs.
THE NEXT USEFUL SIGNAL
What to watch for
Prospective results that separate the contribution of AI from other parts of a program.
The horizon is an editorial scenario for this brief’s central possibility. It does not predict a treatment date or an investment return.